Hepion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Hepion Pharmaceuticals

21/05/2021 12:54

* Hepion Pharmaceuticals Inc  HEPA.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 20 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Hepion Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 12 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Hepion Pharmaceuticals Inc shares had fallen by 6.5% this
quarter and lost 21.5% so far this year.
* The company reported a quarterly loss of $6.06 million.
* Wall Street's median 12-month price target for Hepion
Pharmaceuticals Inc is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 21 at 11:54 a.m. GMT.
​All figures in US dollars